🔎 Trials Near Me

Home › Schizophrenia › Arizona

Schizophrenia clinical trials in Arizona

4 studies for Schizophrenia are looking for participants at sites in Arizona.

Cities in Arizona

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0163, Phoenix
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 6, 2026 · NCT07424404

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Southwest Autism Research and Resource Center, Phoenix
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 3, 2026 · NCT06229210

52-week Open Label Safety-Tolerability Study

  • Chandler Clinical Trials, Chandler
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

  • Reviva site, Phoenix
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.